Isolation of MUC1-primed B lymphocytes from tumour-draining lymph nodes by immunomagnetic beads

Cancer Immunology Immunotherapy

Volumn 47, Issue 5, 1999, Pages 272-277

  Petrarca, Claudia ^a   Casalino, Beniamino ^b   Von Mensdorff Pouilly, Silvia ^c   Rughetti, Aurelia ^a   Rahimi, Hassan ^a   Scambia, Giovanni ^b   Hilgers, Joseph ^c   Frati, Luigi ^a   Nuti, Marianna ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

B lymphocytes; Immune response; Lymph nodes; MUC1; Polymorphic epithelial mucin; Tumour associated antigen

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 4; MONOCLONAL ANTIBODY; MUCIN;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; BREAST CANCER; CANCER; CELL SEPARATION; CLINICAL ARTICLE; ENDOMETRIUM CANCER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HUMORAL IMMUNITY; LYMPH NODE; OVARY CANCER; PRIORITY JOURNAL;

ADULT; AGED; ANTIBODIES, NEOPLASM; B-LYMPHOCYTES; BREAST NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOMAGNETIC SEPARATION; LYMPH NODES; MIDDLE AGED; MUCINS; NEOPLASMS; STOMACH NEOPLASMS;

EID: 0032892403     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050531     Document Type: Article

References (28)

1. 1. Angelopoulou K, Stratis M, Diamandis EP (1997) Humoral immune response against p53 protein in patients with colorectal carcinoma. Int J Cancer 70:46
2. 2. Banchereau J, De Paoli P, Valle' A, Garcia E, Rousset F (1991) Long-term human B-cell lines dependent on interleukin-4 and antibody to CD40. Science 251:70
3. 3. Casali P, Inghirami G, Nakamura M, Davies TF, Notkins AL (1986) Human monoclonals from antigen-specific selection of B lymphocytes and transformation by EBV. Science 234:476.
4. 4. Croce MV, Price MR, Segal-Eiras AE (1995) Expression of monoclonal-antibody-defined antigens in fractions isolated from human breast carcinomas and patients' serum. Cancer Immun Immunother 40:132
5. 5. Fontenot JD, Tjandra N, Bu D, Ho C, Montelaro RC, Finn OJ (1993) Biophysical characterization of one-, two-, and three-tandem repeats of human mucin (MUC-1) protein core. Cancer Res 53:5386
6. 6. Gendler SF, Lancaster CA, Taylor-Papadimitriou J, Duhig T, Peat N, Burchell J, Pumberton L, Lalani EN, Wilson D (1990) Molecular cloning and expression of human tumour-associated polymorphic epithelial mucin. J Biol Chem 265:15286
7. 7. Girling A, Bartkova J, Burchell J, Gendler S, Gillett C, Taylor-Papadimitriou J (1989) A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas. Int J Cancer 43:1072
8. 8. Gourevitch MM, Mensdorff-Pouilly SV von, Litvinov SV, Kenemans P, Kamp GJ van, Verstraeten AA, Hilgers J (1995) Polymorphic epithelial mucin (MUC-1)-containing circulating immune complexes in carcinoma patients. Br J Cancer 72:934
9. 9. Graham RA, Burchell JM, Taylor-Papadimitriou J (1996) The polymorphic epithelial mucin: potential as an immunogen for a cancer vaccine. Cancer Immunol Immunother 42:71
10. 10. Han S, Zheng B, Dal Porto J, Kelsoe G (1995) In-situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. Affinity-dependent, antigen-driven B cell apoptosis in germinal centers as a mechanism for maintaining self-tolerance. J Exp Med 182:1635
11. 11. Jacobs N, Moutschen MP, Greimers R, Schaaf-Lafontaine N (1993) Efficient immmunoselection of cytolytic effectors with a magnetic cell sorter. Res Immunol 144:141
12. 12. Kotera Y, Fontenot JD, Pecher G, Metzgar RS, Finn OJ (1994) Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic and colon cancer patients. Cancer Res 54:2856
13. 13. Livingston P, Zhang S, Adluri S, Yao TJ, Graeber L, Ragupathi G, Helling F, Fleisher M (1997) Tumour cell reactivity mediated by IgM antibodies in sera from melanoma patients vaccinated with GM2 ganglioside covalently linked to KLH is increased by IgG antibodies. Cancer Immunol Immunother 43:324
14. 14. Lores-Vazquez B, Pacheco-Carracedo M, Oliver-Morales J, Parada-Gonzalez P, Gambon-Deza F (1996) Lymphocyte subpopulations of regional lymph nodes in human colon and gastric adenocarcinomas. Cancer Immunol Immunother 42:339
15. 15. Melief CJM, Offringa R, Toes REM, Kast WM (1996) Peptide-based cancer vaccines. Curr Opin Immunol 8:651
16. 16. Mensdorff-Pouilly S von, Gourevitch MM, Kenemans P, Verstraeten AA, Litvinov SV, van Kamp GJ, Mejier S, Vermorken J, Hilgers J (1996) Humoral immune response to polymorphic epithelial mucin (MUC-1) in patients with benign and malignant breast tumours. Eur J Cancer 8:1325
17. 17. Mensdorff-Pouilly S von, Gourevitch MM, Kenemans P, Verstraeten AA, Kamp GJ van, Kok A, Uffelen K van, Snijdewint FGM, Paul MA, Meijer Sybren, Hilgers J (1998) An enzyme-linked immunosorbent assay for the measurement of circulating antibodies to polymorphic epithelial mucin (MUC1). Tumour Biol 19:186
18. 18. Nonoyama S, Hollebaugh D, Aruffo A, Ledbetter JA, Ochs HD (1993) B cell activation via CD40 is required for specific antibody production by antigen stimulated B cells. J Exp Med 178:1097
19. 19. Nuti M, Turchi V, Rughetti A, Viacava P, Masci AM, Castagna M, Frati L (1992) Characterisation of monoclonal antibody 436 recognising the ARG-PRO-ALA-PRO sequence of the polymorphic epithelial mucin (PEM) protein core in breast carcinoma cells. Int J Biol Markers 7:71
20. 20. Nuti M, Rughetti A, Turchi V, Apollonj Ghetti C, Scambia G, Frati L (1993) Human B cell immune response to selected epitopes of the polymorphic epithelial mucin. In Vivo 7:645
21. 21. Petrarca C, Rughetti A, Rahimi H, D'Agostini F, Turchi V, Apollonj Ghetti C, Scambia G, Frati L, Nuti M (1996) Human antibodies against the polymorphic epithelial mucin in ovarian cancer patients recognise a novel sequence in the tandem repeat region. Eur J Cancer 32:2155
22. 22. Pupa SM, Ménard S, Andreola S, Colnaghi MI (1993) Antibody response against the c-erbB-2 oncoprotein in breast carcinoma patients. Cancer Res 53:5864
23. 23. Rousset F, Garcia E, Defrance T, Peronne C, Vezzio N, Hsu D-H, Kastelein R, Moore KW, Banchereau J (1992) Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 89:1890
24. 24. Rughetti A, Turchi V, Apollonj-Ghetti C, Scambia G, Benedetti-Panici P, Roncucci G, Mancuso S, Frati L, Nuti M (1993) Human B-cell immune response to the polymorphic epithelial mucin. Cancer Res 53:2457
25. 25. Schöndorf T, Engel H, Lindemann C, Kolhagen H, Rücker AA von, Mallmann P (1997) Cellular characteristics of peripheral blood lymphocytes in patients with gynaecological tumours. Cancer Immunol Immunother 44:88
26. 26. Taylor-Papadimitriou J, Peterson JA, Arklie J, Burchell J, Ceriani RL, Bodmer WF (1981) Monoclonal antibodies to epithelium specific components of the human milk fat globule membrane: production and reaction with cells in culture. Int J Cancer 28:17
27. 27. Whitford P, Alam SM, George WD, Campbell AM (1992) Flow cytometric analysis of tumour-draining lymph nodes in breast cancer patients. Eur J Cancer 28:350
28. 28. Winter SF, Minna JD, Johnson BE, Takahashi T, Gazdar AF, Carbone DP (1992) Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation. Cancer Res 52:4168